Trial intelligence / Profile preview

Dexmedetomidine brain-protective effects during cardiopulmonary bypass

ChiCTR-IPR-16008169Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Guangxi Medical University
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in Cardiac surgical condition and traumatic brain injury (TBI) (4 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Started Mar 2016; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

Cardiac surgical conditiontraumatic brain injury (TBI)

Beyond the preview

Go deeper on ChiCTR-IPR-16008169.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-16008169.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call